"THE POWER OF 11"

💊 GLP-1 Drugs: Is There a Rug Big Enough?

(Ozempic • Wegovy • Mounjaro • Zepbound)

Imagine a CEO.
Picture him (or her) however you’d like.
We’ll call him (or her) Chris.

Chris runs a massive pharmaceutical firm with a board, stockholders, and tens of billions in revenue.
To keep the machine running, Chris relies on two generals:

➡️ One drives growth — making sure more and more people buy more versions of their “miracle” drug.
➡️ The other handles cleanup — downplaying risk, explaining away side effects, settling quietly, and keeping the media chorus singing, “benefits outweigh risks.”

Now stop imagining.
That’s exactly what’s happening with the new breed of GLP-1 weight-loss drugs.

These injections were never designed for long-term use.
They don’t repair metabolism.
They hack receptor sites — and the fallout (digestive damage, hormonal chaos, bone loss, emotional shifts) is only beginning to surface.

A man emailed me last week:

“My wife tried Ozempic when it first came out, became very sick, lost and gained back 8 pounds, and has never had normal digestion since.
Now she’s found a clinic that ‘micro-doses’ a GLP-1 with insulin needles.
I begged her to talk to you. She won’t… but I got her to register for your Power of 11 webinar.”

That email broke my heart — and reminded me why I speak up.
Because the rug isn’t big enough.

If you want truth instead of spin — if you want to understand how to truly restore metabolism and heal naturally — join me live.

📅 Tuesday, October 28 • 6 PM Eastern
💻 The Power of 11 — Free Live Event